share_log

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $77 Price Target

Guggenheim Reiterates Buy on ANI Pharmaceuticals, Maintains $77 Price Target

古根海姆重申買入ANI Pharmicals,維持77美元的目標股價
Moomoo 24/7 ·  04/23 12:55

Guggenheim analyst Vamil Divan reiterates ANI Pharmaceuticals (NASDAQ:ANIP) with a Buy and maintains $77 price target.

古根海姆分析師瓦米爾·迪萬重申ANI Pharmicals(納斯達克股票代碼:ANIP)的買入並維持77美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論